IMPORTANT JAN 26 DEADLINE: Pawar Law Group Announces a Securities Class Action Lawsuit Against Fortress Biotech, Inc.

NEW YORK, Jan. 19, 2021 (GLOBE NEWSWIRE) – Pawar Law Group announces that it has purchased shares in Fortress Biotech, Inc. (NASDAQ: FBIO) on behalf of shareholders from December 11, 2019 through December 11, 2019 a class action lawsuit was filed on October 9, 2020 inclusive (the “Class Period”). The lawsuit seeks to seek compensation for investors in Fortress Biotech, Inc. under federal securities laws.

To participate in the class action, go here or call Vik Pawar, Esq. toll free at 888-589-9804 or email for information on the class action lawsuit.

According to the lawsuit, the defendants have made false and / or misleading statements and / or failed to disclose that: (1) IV tramadol was unsafe for the intended patient population; (2) As a result, it was foreseeable that the FDA would not approve the NDA for IV tramadol. and (3) as a result, the Company’s public statements at all relevant times have been materially false and misleading.

If you want to appear as the lead plaintiff, you have to move the court at the latest January 26, 2021. A lead plaintiff is a representative party who acts on behalf of other class members in directing the dispute.

No class has been certified. Until a class is certified, you will not be represented by a lawyer unless you hire one. You can hire a lawyer of your choice. You can also do nothing at this point and be an absent member of the class. Your ability to partake in a future recovery does not depend on whether you are the lead plaintiff.

The Pawar Law Group represents investors from all over the world. Lawyer advertising. Past results do not guarantee or forecast a similar result with respect to future matters.

Vik Pawar, Esq.
Pawar Law Group
20 Vesey Street, Suite 1410
New York, NY 10007
Tel .: (917) 261-2277
Fax: (212) 571-0938

Comments are closed.